IRLAB Therapeutics

IRLAB Therapeutics is a pharmaceutical research and development company that provides novel treatment approaches for brain disorders. Mesdopetam (IRL790) and Pirepemat (IRL752) are under development for the treatment of levodopa-induced dyskinesia (LID) and balance impairment leading to falls in Parkinson’s disease (postural dysfunction), which are involuntary movements occurring after long-term use of levodopa treatment in Parkinson’s disease.